{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T15:01:17Z","timestamp":1780930877396,"version":"3.54.1"},"reference-count":26,"publisher":"The Endocrine Society","issue":"5","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Aromatase excess syndrome (AEXS) is a very rare disorder characterized by prepubertal gynecomastia, bone age acceleration, and early growth arrest. Heterozygote submicroscopic rearrangements within the promotor of CYP19A1 result in overexpression of aromatase and enhanced aromatization of androgens.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The objective was to study long-term treatment effects of an aromatase inhibitor.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Data from 7 boys with AEXS were retrospectively collected. Genetic analysis revealed upstream of CYP19A1 a 165 901 bp deletion in 4 German cousins, a 198 662 bp deletion in 2 Japanese brothers, and a 387 622 bp tandem duplication in a Japanese boy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>All boys developed prepubertal gynecomastia, at median 9.0 years of age (range: 7.0-11.0). Height was +1.20 standard deviation score (SDS) (\u20130.24 to +1.98); predicted adult height was -1.29 SDS (-3.29 to +1.09). Four boys were treated with 1.0 mg of anastrozole daily, while 3 reached adult height untreated. Treatment with anastrozole was stopped after 5.6 years (4.0-6.8). Three treated boys exceeded their prognosis by 2.4, 6.9, and 8.1 cm, while 1 untreated boy fell below the prognosis by 8.6 cm. One treated with a low dose and 2 untreated reached their prognosis. Adult heights were \u20130.91 SDS with anastrozole (\u20132.86 to \u20130.29) and \u20130.15 SDS without (\u20132.31 to \u20130.03). Distance to target height was \u20130.22 SDS with anastrozole (\u20131.72 to +0.52) and +0.54 SDS without (+0.23 to +1.30).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Spontaneous growth in AEXS varied, even in the same family. Our data suggest that early started, long-term inhibition by anastrozole promotes adult height in boys with AEXS.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgab054","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T18:15:56Z","timestamp":1611944156000},"page":"1491-1500","source":"Crossref","is-referenced-by-count":7,"title":["Long-term Effect of Aromatase Inhibition in Aromatase Excess Syndrome"],"prefix":"10.1210","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7988-3587","authenticated-orcid":false,"given":"Gerhard","family":"Binder","sequence":"first","affiliation":[{"name":"University Children\u2019s Hospital, Pediatric Endocrinology, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6632-7426","authenticated-orcid":false,"given":"Akie","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Hokkaido University School of Medicine, Department of Pediatrics, Kitaku, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3090-6762","authenticated-orcid":false,"given":"Roland","family":"Schweizer","sequence":"additional","affiliation":[{"name":"University Children\u2019s Hospital, Pediatric Endocrinology, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7178-9991","authenticated-orcid":false,"given":"Tsutomu","family":"Ogata","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hamamatsu University of Medicine, Higashi-ku, Hamamatsu, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9971-4035","authenticated-orcid":false,"given":"Maki","family":"Fukami","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5882-661X","authenticated-orcid":false,"given":"Keisuke","family":"Nagasaki","sequence":"additional","affiliation":[{"name":"Division of Pediatrics, Niigata University Graduate School of Medicine and Dental Science, Niigata, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"issue":"6","key":"2021122205020949500_CIT0001","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1172\/JCI111888","article-title":"Familial gynecomastia with increased extraglandular aromatization of plasma carbon19-steroids","volume":"75","author":"Berkovitz","year":"1985","journal-title":"J Clin Invest."},{"issue":"4","key":"2021122205020949500_CIT0002","first-page":"1348","article-title":"The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription","volume":"83","author":"Stratakis","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"issue":"19","key":"2021122205020949500_CIT0003","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJMoa021559","article-title":"Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene","volume":"348","author":"Shozu","year":"2003","journal-title":"N Engl J Med."},{"issue":"21","key":"2021122205020949500_CIT0004","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/hmg\/ddm145","article-title":"Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) gene","volume":"16","author":"Demura","year":"2007","journal-title":"Hum Mol Genet."},{"issue":"6","key":"2021122205020949500_CIT0005","doi-asserted-by":"crossref","first-page":"E1035","DOI":"10.1210\/jc.2011-0145","article-title":"Aromatase excess syndrome: identification of cryptic duplications and deletions leading to gain of function of CYP19A1 and assessment of phenotypic determinants","volume":"96","author":"Fukami","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2021122205020949500_CIT0006","doi-asserted-by":"crossref","first-page":"E2013","DOI":"10.1210\/jc.2013-2520","article-title":"Genomic basis of aromatase excess syndrome: recombination- and replication-mediated rearrangements leading to CYP19A1 overexpression","volume":"98","author":"Fukami","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021122205020949500_CIT0007","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1210\/jc.2004-1566","article-title":"Dominant transmission of prepubertal gynecomastia due to serum estrone excess: hormonal, biochemical, and genetic analysis in a large kindred","volume":"90","author":"Binder","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021122205020949500_CIT0008","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1586\/17446651.2014.926810","article-title":"Understanding the pathological manifestations of aromatase excess syndrome: lessons for clinical diagnosis","volume":"9","author":"Shozu","year":"2014","journal-title":"Expert Rev Endocrinol Metab."},{"issue":"4","key":"2021122205020949500_CIT0009","doi-asserted-by":"crossref","first-page":"472","DOI":"10.4103\/0971-6866.124379","article-title":"Aromatase excess syndrome presenting with prepubertal gynecomastia in an Egyptian child with type 1 neurofibromatosis","volume":"19","author":"Metwalley","year":"2013","journal-title":"Indian J Hum Genet."},{"issue":"1","key":"2021122205020949500_CIT0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1515\/jpem-2018-0266","article-title":"Aromatase excess syndrome in a Chinese boy due to a novel duplication at 15q21.2","volume":"32","author":"Tan","year":"2019","journal-title":"J Pediatr Endocrinol Metab."},{"key":"2021122205020949500_CIT0011","first-page":"1","article-title":"Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development","volume":"52","author":"Prader","year":"1989","journal-title":"Helv Paediatr Acta Suppl."},{"issue":"2","key":"2021122205020949500_CIT0012","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1297\/cpe.2.87","article-title":"Standard growth charts for height and weight of Japanese children from birth to 17 years based on a cross-sectional survey of national data","volume":"2","author":"Suwa","year":"1993","journal-title":"Clin Pediatr Endocrinol."},{"issue":"239","key":"2021122205020949500_CIT0013","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/adc.45.239.13","article-title":"Variations in the pattern of pubertal changes in boys","volume":"45","author":"Marshall","year":"1970","journal-title":"Arch Dis Child."},{"issue":"244","key":"2021122205020949500_CIT0014","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/adc.45.244.755","article-title":"Standards for children\u2019s height at ages 2-9 years allowing for heights of parents","volume":"45","author":"Tanner","year":"1970","journal-title":"Arch Dis Child."},{"key":"2021122205020949500_CIT0015","volume-title":"Radiograph Atlas of Skeletal Development of the Hand and Wrist.","author":"Greulich","year":"1959","edition":"2"},{"key":"2021122205020949500_CIT0016","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1297\/cpe.2.Supple3_35","article-title":"Japanese specific bone age standard on TW2","volume":"2","author":"Murata","year":"1993","journal-title":"Clin Pediatr Endocrinol"},{"issue":"4","key":"2021122205020949500_CIT0017","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0022-3476(52)80205-7","article-title":"Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards","volume":"40","author":"Bayley","year":"1952","journal-title":"J Pediatr."},{"issue":"10","key":"2021122205020949500_CIT0018","first-page":"1788","article-title":"Prediction of final height in Japanese children using Bayley-Pinneau\u2019s hypothesis","volume":"99","author":"Ito","year":"1995","journal-title":"J Jpn Pediatr Soc."},{"issue":"2","key":"2021122205020949500_CIT0019","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/cen.12329","article-title":"Aromatase excess syndrome in a family with upstream deletion of CYP19A1","volume":"81","author":"Shihara","year":"2014","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"4","key":"2021122205020949500_CIT0020","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1210\/er.2008-0016","article-title":"History of aromatase: saga of an important biological mediator and therapeutic target","volume":"30","author":"Santen","year":"2009","journal-title":"Endocr Rev."},{"issue":"12","key":"2021122205020949500_CIT0021","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.1210\/jc.2005-1392","article-title":"Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial","volume":"90","author":"Hero","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2021122205020949500_CIT0022","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/jbmr.56","article-title":"Vertebral morphology in aromatase inhibitor-treated males with idiopathic short stature or constitutional delay of puberty","volume":"25","author":"Hero","year":"2010","journal-title":"J Bone Miner Res."},{"issue":"9","key":"2021122205020949500_CIT0023","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1210\/jc.2004-0082","article-title":"Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial","volume":"89","author":"Plourde","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021122205020949500_CIT0024","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrendo.2011.161","article-title":"Aromatase inhibitors in pediatrics","volume":"8","author":"Wit","year":"2011","journal-title":"Nat Rev Endocrinol."},{"issue":"11","key":"2021122205020949500_CIT0025","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/sim.3567","article-title":"Stage line diagram: an age-conditional reference diagram for tracking development","volume":"28","author":"van Buuren","year":"2009","journal-title":"Stat Med."},{"issue":"3","key":"2021122205020949500_CIT0026","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1210\/clinem\/dgz196","article-title":"Sex-specific estrogen levels and reference intervals from infancy to late adulthood determined by LC-MS\/MS","volume":"105","author":"Frederiksen","year":"2020","journal-title":"J Clin Endocrinol Metab."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab054\/36150056\/dgab054.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/5\/1491\/41847575\/dgab054.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/5\/1491\/41847575\/dgab054.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T05:02:36Z","timestamp":1640149356000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/106\/5\/1491\/6123853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,1,29]]},"published-print":{"date-parts":[[2021,4,23]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab054","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,5,1]]},"published":{"date-parts":[[2021,1,29]]}}}